Butterfly Network, Inc.
BFLY NYSE X-Ray Apparatus & Tubes & Related Irradiation Apparatus Financials FY2019โFY2025
Last close ยท Oct 23, 2026
$6.76
0.7%What Butterfly Network, Inc. does
No business description yet.
- Legal name
- Butterfly Network, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K ยท Feb 27, 2026
- Accession ยท CIK
- 0001804176-26-000009
0001804176
Revenue and margins
Butterfly Network, Inc. had $97.6M of revenue in fiscal 2025, up 19.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$16.0M in fiscal 2025, โ16.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Butterfly Network, Inc. returned โ to shareholders in fiscal 2025. The diluted share count rose 16.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Butterfly Network, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $423M | $238M | $134M | $88.8M | $150M |
| Interest coverage | โ296.0x | โ96,510.0x | โ | โ59.0x | โ58.0x |
| Current ratio | 10.3x | 7.0x | 5.2x | 4.0x | 3.8x |
| Quick ratio | 9.5x | 5.8x | 3.6x | 2.5x | 2.9x |
| Total assets | $572M | $418M | $304M | $256M | $297M |
| Total liabilities | $124M | $92.2M | $84.2M | $87.3M | $101M |
| Shareholders' equity | $448M | $325M | $220M | $169M | $196M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 5 | 3 / 8 | 2 / 8 | 2 / 8 | 4 / 8 | 3 / 8 |
| Accruals ratio | โ | โ55.1% | 43.6% | 0.1% | โ9.7% | โ11.0% | โ23.3% |
| Altman Z'' | โ | โ17.46 | 4.38 | 0.75 | โ4.26 | โ6.43 | โ5.51 |
7 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $27.6M | $46.3M | $62.6M | $73.4M | $65.9M | $82.1M | $97.6M |
| Gross profit | โ$20.9M | โ$61.2M | $17.1M | $39.5M | $16.9M | $48.8M | $45.7M |
| Research and development | $48.9M | $49.7M | $74.5M | $88.0M | $55.6M | $37.8M | $36.3M |
| Operating income | โ$102M | โ$162M | โ$193M | โ$193M | โ$146M | โ$74.4M | โ$86.4M |
| Interest expense | โ | $1.1M | $0.7M | $0.0M | $0.0M | $1.3M | $1.5M |
| Pretax income | โ$99.7M | โ$163M | โ$32.3M | โ$169M | โ$134M | โ$72.5M | โ$77.0M |
| Income tax | โ | $0.0M | $0.1M | $0.0M | $0.1M | โ$0.0M | $0.1M |
| Net income | โ$99.7M | โ$163M | โ$32.4M | โ$169M | โ$134M | โ$72.5M | โ$77.1M |
| Net income to common | โ | โ$163M | โ$32.4M | โ$169M | โ$134M | โ$72.5M | โ$77.1M |
| Diluted EPS | โ$17.08 | โ$26.87 | โ$0.19 | โ$0.84 | โ$0.65 | โ$0.34 | โ$0.31 |
| Diluted shares | 0.01B | 0.01B | 0.17B | 0.20B | 0.21B | 0.21B | 0.25B |
| Cash flow | |||||||
| Cash from operations | โ$120M | โ$81.7M | โ$189M | โ$169M | โ$98.8M | โ$41.7M | โ$12.7M |
| Capital expenditure | $4.5M | $2.4M | $7.9M | $18.3M | $5.8M | $2.7M | $3.3M |
| Free cash flow | โ$125M | โ$84.1M | โ$197M | โ$187M | โ$105M | โ$44.4M | โ$16.0M |
| Depreciation and amortization | $0.8M | $1.3M | $2.1M | $5.9M | $8.7M | $8.9M | $6.7M |
| Stock-based compensation | $6.0M | $11.0M | $47.8M | $42.5M | $27.5M | $21.0M | $23.4M |
| Balance sheet | |||||||
| Cash and short-term investments | $90.0M | $60.2M | $423M | $238M | $134M | $88.8M | $150M |
| Current assets | โ | $97.3M | $512M | $357M | $231M | $193M | $249M |
| Current liabilities | โ | $69.7M | $49.8M | $51.3M | $44.3M | $48.2M | $65.1M |
| Inventory | โ | $25.8M | $36.2M | $60.0M | $73.0M | $70.8M | $61.4M |
| Property and equipment, net | โ | $6.9M | $14.7M | $31.3M | $25.3M | $19.5M | $16.6M |
| Intangible assets | โ | โ | โ | โ | $10.3M | $8.9M | $7.5M |
| Total assets | โ | $147M | $572M | $418M | $304M | $256M | $297M |
| Total liabilities | โ | $148M | $124M | $92.2M | $84.2M | $87.3M | $101M |
| Shareholders' equity | โ$212M | โ$362M | $448M | $325M | $220M | $169M | $196M |
| Margins | |||||||
| Gross margin | โ75.8% | โ132.4% | 27.3% | 53.8% | 25.6% | 59.5% | 46.9% |
| Operating margin | โ370.9% | โ349.4% | โ308.0% | โ263.0% | โ221.0% | โ90.7% | โ88.5% |
| EBITDA margin | โ368.1% | โ346.6% | โ304.7% | โ255.0% | โ207.8% | โ79.8% | โ81.7% |
| Net margin | โ361.4% | โ351.9% | โ51.8% | โ229.9% | โ202.9% | โ88.3% | โ79.0% |
| FCF margin | โ452.8% | โ181.8% | โ315.0% | โ255.4% | โ158.7% | โ54.1% | โ16.4% |
| Returns | |||||||
| Return on capital employed | โ | โ208.6% | โ36.9% | โ52.7% | โ56.0% | โ35.8% | โ37.3% |
| Return on equity | โ | โ | โ75.6% | โ43.7% | โ49.0% | โ37.3% | โ42.2% |
| Return on assets | โ | โ110.6% | โ9.0% | โ34.1% | โ37.0% | โ25.9% | โ27.9% |
| Return on tangible equity | โ | โ | โ7.2% | โ51.9% | โ63.7% | โ45.3% | โ40.9% |
| Growth | |||||||
| Revenue growth | โ | 67.7% | 35.3% | 17.3% | โ10.2% | 24.5% | 19.0% |
| Share count change | โ | 3.7% | 2,769.8% | 15.0% | 2.8% | 3.1% | 16.7% |
| Financial health | |||||||
| Interest coverage | โ | โ141.6x | โ296.0x | โ96,510.0x | โ | โ59.0x | โ58.0x |
| Current ratio | โ | 1.4x | 10.3x | 7.0x | 5.2x | 4.0x | 3.8x |
| Quick ratio | โ | 1.0x | 9.5x | 5.8x | 3.6x | 2.5x | 2.9x |
| Capital allocation | |||||||
| Capex / revenue | 16.2% | 5.1% | 12.6% | 24.9% | 8.8% | 3.3% | 3.4% |
| Stock comp / revenue | 21.9% | 23.8% | 76.4% | 58.0% | 41.7% | 25.6% | 24.0% |
| Quality scores | |||||||
| Piotroski F-score | โ | โ | 3.0 | 2.0 | 2.0 | 4.0 | 3.0 |
| Altman Z'' | โ | โ17.5 | 4.4 | 0.8 | โ4.3 | โ6.4 | โ5.5 |
| Accruals ratio | โ | โ55.1% | 43.6% | 0.1% | โ9.7% | โ11.0% | โ23.3% |
Source: SEC EDGAR XBRL filings (CIK 0001804176). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
